New York Genome Center-founded Gencove has added $3m from investors including Alexandria Venture Investments to bring its genomics testing kit to new markets.

The medical research services provider collected funding from investors including Cash Capital, an investment arm of CAS which previously backed a series A.

MIT's The Engine has returned to back membrane-based separation technology spinout Via Separations, after previously investing an undisclosed sum in 2017.

Scotiabank has supplied University of Calgary-affiliated Well Doc Alberta with funding under a pact signed when it bought MD Financial Management last year.

The series A round reportedly featured UCLA Ventures, with the cash going towards expanding the business and technology for FanFood’s events concession app.

Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.

The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution.

Ghent-founded indoor position technology business Pozyx has amassed more than $1.5m having recently completed the launch of its initial product range.